WEEKLY UPDATE / 14 Jul 2025

Hello!

This week, Eric Schneider and Nancy Holekamp talk to us about how Notal’s Home OCT system currently works for monitoring neovascular age-related macular degeneration (nAMD) progression, as well as whether the AI algorithm can keep up with the accuracy of human graders, and how close the tech currently stands to seeing widespread adoption in the US.

Alongside the benefits of having self-administered at-home patient monitoring, Holekamp and Schneider point to ongoing barriers to the tech currently being integrated on a large-scale basis, including financial considerations, some litigation concerns, and, as Schneider phrases it, “Inertia… People are very used to doing things the way they have always been done.”

Do you have concerns about the legalities or finances with incorporating this kind of device into your practice? Or can you see the benefits of outsourcing some of this type of monitoring and care to the patient themselves? As always, we’d love to hear from you: [email protected].

Until next time!

Alun Evans, Deputy Editor

Essential Reading

Personalizing Cataract Surgery with Advanced Technologies
The Light Adjustable Lens (LAL) represents more than just an innovative IOL. It’s a practice builder and a game-changer in modern cataract surgery, writes I. Paul Singh (pictured above), President of The Eye Centers of Racine & Kenosha, Wisconsin. Link

Embracing an Interventional Mindset
Deborah Ristvedt of Vance Thompson Vision, Minnesota, offers her thoughts on how interventional glaucoma represents a major paradigm shift for glaucoma treatment. Link

More from The Ophthalmologist

Key Ocular Health Indicators in Early Adulthood
New research from the University of Western Australia has examined data from the Raine study in order to better establish normative values for ocular changes in early adulthood.
Link

Full of Pep
Peptide-based eye drops show promise as RP treatment, slowing photoreceptor degeneration in animal models, says recent Communications Medicine study.
Link

Also in the News...

New findings for age-related vision awareness. A Roche-commissioned report – the APAC Vision Health Survey – has revealed surprising insights into how 40+ aged adults regard the importance of vision health and care in their everyday lives. Link

Sustainable education. The Centre for Ocular Research & Education (CORE) at the University of Waterloo, Canada, last week launched SustainableEyecare.com, a first-of-its-kind website aimed at educating both patients and eye care professionals about the environmental impacts of eyewear and contact lenses. Link

LBN for glaucoma. Frontiers in Ophthalmology has published The Canadian Latanoprostene Bunod Early Experience Program (LEEP), a study evaluating the real-world effectiveness of LBN 0.024% for open-angle glaucoma and ocular hypertension. Looking at 653 patients, the study concluded that both patient and physician satisfaction with LBN were high, with prior selective laser trabeculoplasty (SLT) history not significantly diminishing LBN's IOP-lowering efficacy. Link

DED detection. A recent longitudinal study assessed young adults with and without evaporative dry eye disease (DED), finding that over 90 percent showed at least one sign of ocular surface disease, with significant progression over a year in redness, lid wiper epitheliopathy, and blink rate. The findings highlight the importance of early detection and intervention for DED, emphasizing modifiable risk factors like screen use, contact lens wear, and stress. Link

This email was sent to by [email protected]. To ensure delivery of emails to your inbox, please add [email protected] to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Ophthalmologist is a brand of Texere Publishing Limited (trading as Conexiant)

Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.